EE261 Cost-Effectiveness of Adding Darolutamide to Docetaxel and Androgen Deprivation Therapy in the Treatment of Metastatic Hormone-Sensitive Prostrate Cancer
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.562
https://www.valueinhealthjournal.com/article/S1098-3015(23)00662-9/fulltext
Title :
EE261 Cost-Effectiveness of Adding Darolutamide to Docetaxel and Androgen Deprivation Therapy in the Treatment of Metastatic Hormone-Sensitive Prostrate Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00662-9&doi=10.1016/j.jval.2023.03.562
First page :
Section Title :
Open access? :
No
Section Order :
10044